1. Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors

    Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors

    ...tumor-selective immunotherapies for patients with cancer, today announced the appointment of Paul J. Clancy to its Board of Directors. Mr. Clancy is...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Paul is a highly respected leader in the biotechnology community and brings a wealth of strategic and operational experience that will support Xilio through this stage of rapid growth of the company.
    2. Xilio Therapeutics is at an exciting stage in its growth trajectory and has the potential to be a leader in developing highly potent immunotherapies that are selectively activated in tumors.
  3. Topics Mentioned